Zhang DK - Search Results

1

Eradication rates of Helicobacter pylori in treatment-naive patients following 14-day vonoprazan-amoxicillin dual therapy: A multicenter randomized controlled trial in China.

Hu J, Mei H, Su NY, Sun WJ, Zhang DK, Fan LL, He P, Pan J, Wang XW, Zou PY, Liu YX, Guo Y, Lan CH. Hu J, et al. Among authors: zhang dk. Helicobacter. 2023 Aug;28(4):e12970. doi: 10.1111/hel.12970. Epub 2023 May 9. Helicobacter. 2023. PMID: 37160689 Clinical Trial.

2

The high-dose amoxicillin-proton pump inhibitor dual therapy in eradication of Helicobacter pylori infection.

Yun J, Wu Z, Qi G, Han T, Zhang D. Yun J, et al. Expert Rev Gastroenterol Hepatol. 2021 Feb;15(2):149-157. doi: 10.1080/17474124.2021.1826306. Epub 2020 Oct 8. Expert Rev Gastroenterol Hepatol. 2021. PMID: 32960107 Review.

3

Diagnosis and treatment of Helicobacter pylori infection by physicians in China: A nationwide cross-sectional study.

Song Z, Chen Y, Lu H, Zeng Z, Wang W, Liu X, Zhang G, Du Q, Xia X, Li C, Jiang S, Wu T, Li P, He S, Zhu Y, Zhang G, Xu J, Li Y, Huo L, Lan C, Miao Y, Jiang H, Chen P, Shi L, Tuo B, Zhang D, Jiang K, Wang J, Yao P, Huang X, Yang S, Wang X, Zhou L. Song Z, et al. Helicobacter. 2022 Jun;27(3):e12889. doi: 10.1111/hel.12889. Epub 2022 Apr 1. Helicobacter. 2022. PMID: 35363917

4

High-dose amoxicillin-proton pump inhibitor dual therapy as first-line treatment for Helicobacter pylori infection in Northwest China: A prospective, randomised controlled trial.

Yun JW, Wang C, Yu Y, Xu HM, Gou LZ, Li XL, Yi GR, Lin YM, Han TY, Zhang DK. Yun JW, et al. Among authors: zhang dk. Br J Clin Pharmacol. 2023 Jan;89(1):232-241. doi: 10.1111/bcp.15488. Epub 2022 Aug 21. Br J Clin Pharmacol. 2023. PMID: 35947524 Free article. Clinical Trial.

5

The efficacy of vonoprazan combined with different dose amoxicillin on eradication of Helicobacter pylori: an open, multicenter, randomized clinical study.

Lin Y, Xu H, Yun J, Yu X, Shi Y, Zhang D. Lin Y, et al. Ann Transl Med. 2022 Sep;10(18):987. doi: 10.21037/atm-22-4133. Ann Transl Med. 2022. PMID: 36267745 Free PMC article.

6

Efficacy and safety of high-dose esomeprazole and amoxicillin dual therapy versus bismuth-containing quadruple therapy for Helicobacter pylori infection: a multicenter, randomized controlled clinical trial.

Mei H, Guo Y, Zhao JT, Yang J, Sun WJ, Zhang DK, He P, Shi G, Su NY, Han R, Lan CH. Mei H, et al. Among authors: zhang dk. Therap Adv Gastroenterol. 2022 Dec 26;15:17562848221142925. doi: 10.1177/17562848221142925. eCollection 2022. Therap Adv Gastroenterol. 2022. PMID: 36600686 Free PMC article.

7

Colloidal bismuth pectin-containing quadruple therapy as the first-line treatment of Helicobacter pylori infection: A multicenter, randomized, double-blind, non-inferiority clinical trial.

Xie Y, Hu Y, Zhu Y, Wang H, Wang QZ, Li YQ, Wang JB, Zhang ZY, Zhang DK, Liu XW, Lu NH. Xie Y, et al. Among authors: zhang dk, zhang zy. Helicobacter. 2023 Jun;28(3):e12978. doi: 10.1111/hel.12978. Epub 2023 Mar 31. Helicobacter. 2023. PMID: 37002653 Clinical Trial.

8

Research progress in photodynamic therapy for Helicobacter pylori infection.

Luo Q, Liu C, Zhang A, Zhang D. Luo Q, et al. Helicobacter. 2024 Mar-Apr;29(2):e13068. doi: 10.1111/hel.13068. Helicobacter. 2024. PMID: 38497573 Review.

9

[Jinghuaweikang capsules combined with Quadruple therapy in the treatment of Helicobacter pylori infection:a multicenter,randomized,controlled,clinical study].

Yang Q, Shang Q, Wei GQ, Guo QH, Ka SQ, Zhang ZY, Li FW, Shen XP, Zhang DK. Yang Q, et al. Among authors: zhang dk, zhang zy. Zhonghua Yi Xue Za Zhi. 2019 Jan 22;99(4):295-300. doi: 10.3760/cma.j.issn.0376-2491.2019.04.012. Zhonghua Yi Xue Za Zhi. 2019. PMID: 30669717 Clinical Trial. Chinese.

10

Comparative efficacy and safety of high-dose dual therapy, bismuth-based quadruple therapy and non-bismuth quadruple therapies for Helicobacter pylori infection: a network meta-analysis.

Xu H, Wang W, Ma X, Feng R, Su Y, Cheng L, Yang Y, Zhang D. Xu H, et al. Eur J Gastroenterol Hepatol. 2021 Jun 1;33(6):775-786. doi: 10.1097/MEG.0000000000001835. Eur J Gastroenterol Hepatol. 2021. PMID: 32639419

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

232 results

Search Page